Month: April 2020

TORONTO, April 28, 2020 (GLOBE NEWSWIRE) — Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (“Auxly” or the “Company”) is pleased to announce that it has entered into an investment agreement (the “Agreement”) with an institutional investor (the “Investor”) as a standby facility to provide the Company with access to additional capital. This provides the Company with the opportunity to sell, on a private placement basis, unsecured convertible debentures of the Company (collectively, the “Convertible Debentures”) in the principal amount of up to $25,000,000 (the “Offering“). The Convertible Debentures will be issuable in tranches at the request of the Company, as described in greater detail below.“Auxly’s focus on ‘Cannabis 2.0’ and our ability to execute on delivering a compelling portfolio of branded cannabis products...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESMISSISSAUGA, Ontario, April 28, 2020 (GLOBE NEWSWIRE) — Maplewood International Real Estate Investment Trust (the “REIT”), listed on the NEX board of the TSX Venture Exchange (the “TSXV”), announced today that it will file a management information circular (the “Circular”) in connection with a special meeting of unitholders of the REIT (the “Unitholders”) to be held on May 28, 2020, (the “Special Meeting”) to approve a special resolution of Unitholders with respect to the termination of the REIT pursuant to the terms of the REIT’s amended and restated declaration of trust dated September 9, 2013 (the “REIT Termination”). The REIT Termination will be more particularly described in the Circular, which is expected to be mailed to Unitholders...

TORTOLA, British Virgin Islands, April 28, 2020 (GLOBE NEWSWIRE) — Orca Exploration Group Inc. (“Orca” or “the Company” and includes its subsidiaries and affiliates) (TSX-V: ORC.A, ORC.B) today announces its audited financial results for the year ended December 31, 2019. All dollar amounts are in United States dollars unless otherwise stated.Revenue for 2019 increased by 48% to $85.6 million and 72% to $23.2 million for Q4 2019 over the comparable prior year period. The increases are primarily due to increased sales to the Tanzanian Electric Supply Company Limited (“TANESCO”), sales to the Tanzanian Production Development Corporation (“TPDC”) under the new long-term gas sales agreement (“LTGSA”), a greater percentage of profit share and a positive current income tax adjustment as a consequence of higher revenues....

Net Income of $5.05 Million and EPS of $0.60Allowance for Loan Losses Increased 20%Return on Average Assets of 1.56%Return on Average Equity of 11.39%Announces $0.20 Quarterly Cash DividendHOQUIAM, Wash., April 28, 2020 (GLOBE NEWSWIRE) — Timberland Bancorp, Inc. (NASDAQ: TSBK) (“Timberland” or “the Company”) today reported net income of $5.05 million for the quarter ended March 31, 2020 compared to $6.11 million for the comparable quarter one year ago and $6.65 million for the preceding quarter.  Earnings per diluted common share (“EPS”) were $0.60 for the current quarter compared to $0.72 for the comparable quarter one year ago and $0.78 for the preceding quarter.  Net income for the quarter ended March 31, 2020 was reduced by a $2.00 million provision to the loan loss reserve due to the economic uncertainties associated with...

VANCOUVER, British Columbia, April 28, 2020 (GLOBE NEWSWIRE) — Affinor Growers Inc. (“AFI” or the “Company”) (CSE:AFI, OTC:RSSFF, Frankfurt:1AF) announces a postponement in its Q3 Interim Filings.The filing of the Company’s unaudited interim financial statements (the “Financial Statements”) and corresponding management’s discussion and analysis (the “MD&A”) for the nine months ended February 29, 2020 are being postponed due to delays caused by the COVID-19 pandemic. Affinor is relying on the Blanket Exemption Order to postpone the filing of the Financial Statements required by section 4.2 of National Instrument 51-102 and the filing of the MD&A required by subsection 5.1(2) of National Instrument 51-102.The Company expects to file the Financial Statements and MD&A on SEDAR on or...

La désignation “Fast Track” souligne le besoin urgent de nouvelles options thérapeutiques potentielles pour le traitement de seconde ligne des patients atteints d’un cancer du pancréas métastatiqueLYON, France, 28 avr. 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Euronext Paris et Nasdaq : ERYP), société biopharmaceutique de stade clinique qui développe des thérapies innovantes en encapsulant des médicaments dans les globules rouges, annonce aujourd’hui que la Food and Drug Administration (FDA) américaine a accordé la désignation “Fast Track” à eryaspase pour le développement d’un traitement de seconde ligne des patients atteints d’un cancer du pancréas métastatique.« C’est une nouvelle étape importante et une validation significative de notre technologie alors que nous poursuivons notre étude de phase 3 TRYbeCA-1...

Fast Track designation for eryaspase underscores the urgent need for potential new treatment options for patients with second line metastatic pancreatic cancerLYON, France and CAMBRIDGE, Mass., April 28, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, announced today that the U.S. Food and Drug Administration (FDA) has granted eryaspase Fast Track Designation for the development of a second-line treatment of patients with metastatic pancreatic cancer.“This is yet another significant milestone and meaningful validation of our technology as we continue our TRYbeCA-1 Phase 3 trial evaluating eryaspase in second-line metastatic pancreatic cancer,” said Gil Beyen, CEO of...

TORONTO, April 28, 2020 (GLOBE NEWSWIRE) — ZoomerMedia Limited (TSXV:ZUM) (the “Company”), the leader in serving the interests of the 45+ “Zoomer” market in Canada, today announced its financial results for the second quarter ended February 29, 2020.Consolidated ResultsFor the six months ended February 29, 2020 the Company generated revenues of $27.9 million, operating expenses of $22.8 million and Adjusted EBITDA of $5.1 million. Net income for the same period was $1.3 million.For the comparative six months ended February 28, 2019 the Company had revenues of $26.6 million, operating expenses of $24.5 million and Adjusted EBITDA of $2.2 million. Net income for the three months was $0.5 million.EBITDA and Adjusted EBITDA are non-IFRS earnings measures which do not have any standardized meaning prescribed by IFRS and therefore may...

NOVATO, Calif., April 28, 2020 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultra-rare diseases, today announced that clinical, preclinical and manufacturing data from its investigational gene therapy programs will be presented at the American Society of Gene & Cell Therapy (ASGCT) 23rd Annual Meeting, which will be held virtually May 12-15, 2020. Information will be available at www.asgct.org.Nine Ultragenyx abstracts have been accepted for virtual presentation, including:An oral presentation of available data from the confirmatory cohort of the  Phase 1/2 study of DTX401, an AAV-based gene therapy for the treatment of glycogen storage disease Type Ia (GSDIa) (Abstract #1306)An oral presentation...

ROAD TOWN, British Virgin Islands, April 28, 2020 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (“Aura” or the “Company”) today provided a further update regarding the interruption of operations at its San Andres Mine in Honduras in response to COVID-19 which Aura first announced on March 29, 2020 and provided an update on April 20, 2020.On March 26, 2020, the Honduran government issued a new official communication in which the government extended its previously-issued decree (the “Government Orders”) requiring Aura to operate with a minimal work force for general maintenance no greater than 50 people until May 3, 2020. Minerales de Occidente, S.A. de C.V., the Company’s subsidiary which owns the surface and mineral rights of the San Andres Mine, initially obtained authorization to continue leaching activities, but has since...